ERAS Shareholder Alert: Erasca, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Erasca Allegedly Raised $258.8 Million Through a Shelf Registration Statement While Concealing Patent Infringement Risk and Improper Preclinical Comparisons for Its Lead Drug Candidate NEW YORK, July 15, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP announces that a securities class action...